Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an …
CN Sternberg, I Skoneczna, JM Kerst, P Albers… - The lancet …, 2015 - thelancet.com
Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor
survival after cystectomy. The EORTC 30994 trial aimed to compare immediate versus …
survival after cystectomy. The EORTC 30994 trial aimed to compare immediate versus …
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients
Purpose: We describe the cancer related outcome in patients with pT0 bladder urothelial
carcinoma at radical cystectomy who did not receive preoperative chemotherapy in a large …
carcinoma at radical cystectomy who did not receive preoperative chemotherapy in a large …
Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
S Denzinger, HM Fritsche, W Otto, A Blana… - European urology, 2008 - Elsevier
OBJECTIVES: We compared long-term outcome in patients with initial pT1G3 bladder
cancer (BC) treated with early versus deferred cystectomy (CX) for recurrent pT1G3 or …
cancer (BC) treated with early versus deferred cystectomy (CX) for recurrent pT1G3 or …
Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients
RE Hautmann, RC de Petriconi, C Pfeiffer, BG Volkmer - European urology, 2012 - Elsevier
BACKGROUND: The optimal treatment strategy for muscle-invasive bladder cancer (BCa)
remains controversial. OBJECTIVE: Better define the long-term outcomes of radical …
remains controversial. OBJECTIVE: Better define the long-term outcomes of radical …
Final pathological stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer—does pT0 predict better survival than pTa/Tis/T1?
H Zargar, K Zargar-Shoshtari, Y Lotan… - The Journal of …, 2016 - auajournals.org
Purpose: We assessed survival dependent on pathological response after neoadjuvant
chemotherapy in a large multicenter patient cohort, with a particular focus on the difference …
chemotherapy in a large multicenter patient cohort, with a particular focus on the difference …
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Background Previous randomised controlled trials comparing bladder preservation with
radical cystectomy for muscle-invasive bladder cancer closed due to insufficient accrual …
radical cystectomy for muscle-invasive bladder cancer closed due to insufficient accrual …
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort
HM Fritsche, M Burger, RS Svatek, C Jeldres… - European urology, 2010 - Elsevier
BACKGROUND: Management of T1 grade 3 (T1G3) urothelial carcinoma of the bladder
(UCB), with its variable behaviour, represents one of the most difficult challenges for …
(UCB), with its variable behaviour, represents one of the most difficult challenges for …
Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the University of Southern California …
AP Mitra, J Cai, G Miranda, S Bhanvadia… - The Journal of …, 2022 - auajournals.org
Purpose: There are conflicting reports on outcome trends following radical cystectomy (RC)
for bladder cancer. Materials and Methods: Evolution of modern bladder cancer …
for bladder cancer. Materials and Methods: Evolution of modern bladder cancer …
Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder
T Seisen, M Sun, SR Lipsitz, F Abdollah, JJ Leow… - European urology, 2017 - Elsevier
Given the lack of randomized evidence comparing trimodal therapy (TMT) to radical
cystectomy (RC) for muscle-invasive urothelial carcinoma of the bladder (UCB), we …
cystectomy (RC) for muscle-invasive urothelial carcinoma of the bladder (UCB), we …
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
F Freiha, J Reese, FM Torti - The Journal of urology, 1996 - auajournals.org
Purpose: Standard treatment for muscle invasive transitional cell cancer of the bladder is
radical cystectomy. Despite careful staging, the majority of cancers with regional lymph node …
radical cystectomy. Despite careful staging, the majority of cancers with regional lymph node …
相关搜索
- radical cystectomy urothelial carcinoma
- radical cystectomy bladder cancer
- outcomes of patients urothelial carcinoma
- radical cystectomy outcomes of patients
- patients with pt3 deferred chemotherapy
- deferred chemotherapy urothelial carcinoma
- adjuvant therapy urothelial carcinoma
- radical cystectomy adjuvant therapy
- radical cystectomy deferred chemotherapy
- radical cystectomy pta tis
- methotrexate chemotherapy bladder cancer
- radical cystectomy weighted analysis
- pta tis bladder cancer
- trimodality therapy bladder cancer
- evolution of the university urothelial carcinoma
- management trends urothelial carcinoma